FindTrial
Sign In

To study the effect of fat dissolving for mastoscopic axillary lymph node dissection on the regulation of the immunity of breast cancer patients

To study the effect of fat dissolving for mastoscopic axillary lymph node dissection on the regulation of the immunity of breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015950
Enrollment
Unknown
Registered
2018-05-02
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

open surgery group:Conventional axillary lymph node dissection
Mastoscopic surgery group*:Mastoscopic axillary lymph node dissection

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 100 Years

Inclusion criteria

Inclusion criteria: Operable breast cancer patients (I-III)

Exclusion criteria

Exclusion criteria: Patients with history of armpit surgery

Design outcomes

Primary

MeasureTime frame
Tumor-associated macrophage,TAM1;Tumor-associated macrophage,TAM2;natural killer cells;cytotoxic T cell;leptin;adiponectin;CD4+T cell;CD8+T cell;tregT cell;—

Countries

China

Contacts

Public ContactDing Boni

The Third Xiangya Hospital of Central South University

dingboni@aliyun.com+86 13627418663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026